A comprehensive review of vascular complications in COVID-19

Yogesh Acharya1, Aqeel Alameer2, Gavin Calpin3

  • 1Department of Vascular and Endovascular Surgery, Western Vascular Institute, University Hospital Galway, National University of Ireland, Newcastle Road, H91 YR71, Galway, Ireland.

Insights

COVID-19 causes systemic inflammation and a hypercoagulable state, leading to vascular complications like thrombosis. More research is needed on managing these vascular issues and anticoagulation strategies for better patient outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Hematology

Background:

  • COVID-19 is associated with systemic inflammation and a procoagulant state.
  • Vascular complications, including thrombosis and endothelial dysfunction, are frequently observed in COVID-19 patients.
  • Dysfunctional coagulation pathways are evident, yet large-scale studies on vascular complications are limited.

Purpose of the Study:

  • To review existing literature on vascular complications in COVID-19.
  • To highlight the need for specialized studies and clear management guidelines for COVID-19-associated vascular issues.
  • To emphasize the importance of understanding pathogenesis, epidemiology, and outcomes for risk stratification and treatment.

Main Methods:

  • Systematic literature search using PubMed and Google Scholar.
  • Identification of relevant studies based on the objective of reviewing vascular complications in COVID-19.
  • Analysis of reported data on inflammation, coagulation, and thrombotic events.

Main Results:

  • Multiple studies confirm widespread inflammation and a hypercoagulable state in COVID-19.
  • Reported complications include thrombotic microangiopathy, endothelial dysfunction, bleeding disorders, and thrombosis.
  • Hypercoagulability and vascular complications are significant predictors of patient outcomes.

Conclusions:

  • There is a critical need for large, specialized studies on COVID-19 vascular complications.
  • Definitive recommendations for thromboprophylaxis and anticoagulation in COVID-19 are lacking.
  • Understanding these vascular issues is crucial for effective risk stratification and patient management.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
67
Overview of the Vascular System01:20

Overview of the Vascular System

The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
3.1K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
74
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
64
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
43
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
57